Donor Variability in Ex Vivo Human Tissue Studies: Challenge, Feature, or Translational Advantage
Explore how donor variability in ex vivo human tissue studies enhances translational research by providing insights into patient heterogeneity and improving drug discovery.
12 March 2026
REPROCELL Attends Japan-Maryland Night 2026
REPROCELL was honored to attend Japan-Maryland Night on Wednesday March 4th 2026 Maryland State, USA, hosted by the Embassy of Japan (in Washington DC).
06 March 2026
REPROCELL’s Global Biorepository, the solution to your human tissue sample requirements
Our biorepository's carefully governed infrastructure ensures specimens are collected, processed, stored, and distributed under rigorous, standardized conditions.
23 October 2025
Prince George’s County Economic Development Corporation Visits REPROCELL USA
REPROCELL USA hosts Prince George's County Economic Development Corporation, showcasing their biotech services and highlighting the benefits of operating in PG County.
03 March 2025
REPROCELL Makes its First Appearance at Japan-Maryland Night
REPROCELL made its debut at Japan-Maryland Night, fostering connections with political and scientific communities to further its mission and showcase its genomic services.
18 February 2025
Plasma or Serum? – You Decide
Discover the key differences between plasma and serum, their collection methods, and their impact on clinical and experimental outcomes.
17 October 2024
Need To Conduct a Multi-Variable Study? REPROCELL Can Help with That!
Conducting a multi-variable study on cancer risk and family history? Discover how our biorepository and custom collections can assist in your research.
18 July 2024
REPROCELL USA Inaugurates New GMP Laboratory
May 15, 2024: REPROCELL USA inaugurated its new GMP BioManufacturing Lab. The facility enables hiPSC and hMSC generation in a contaminant-free environment.
07 June 2024
Wire myography: the ultimate guide (protocol included)
Learn how to measure the reactivity and functional response of arteries in the wire myograph system in our wire myograph protocol.
25 April 2023
Alternative testing methods covered by the FDA Modernization Act 2.0
Discover whether the FDA Modernization Act 2.0. will increase the use of non-animal, alternative testing methods in drug development.
06 March 2023
REPROCELL: What makes our human tissue biorepository stand out?
Disocver REPROCELL, a leader in its industry located in Maryland that is home to over 600,000 biospecimens collected from approximately 120,000 donors.
04 August 2022
What is Human Tissue Testing?
Discover the definition of human tissue testing and how it can enhance your drug discovery research on the REPROCELL blog.
14 March 2022
How we established an in vitro Parkinson’s Disease model
Discover how to establish an in vitro Parkinson’s Disease model using iPSC-derived neurons - from patient screening to neuronal maturation.
24 November 2021
Human tissue testing and precision medicine
Find out how a recent nature article has sparked interest in the use of human tissue testing for precision medicine.
08 June 2021
Improving precision medicine strategies with human tissue testing
Discover how you can improve your precision medicine strategies with human tissue testing.
29 April 2021
Tissue Sourcing for the Development of iPSC-derived Disease Models
Looking to source primary tissues for iPSC generation? Find out more about tissue sourcing for the development of iPSC-derived disease models.
06 February 2019
How animal testing is inaccurate and the alternatives
Find out how animal experimentation can lead to adverse drug effects on the REPROCELL blog.
25 May 2018
Human Tissue Testing in Drug Discovery and Development
Discover how human tissue testing can be used in drug discovery and development to make the process smarter and more efficient.
27 March 2018